What is Rael?
Rael offers a comprehensive range of holistic health products focused on menstrual and cycle care, encompassing items such as pads, tampons, supplements, and skincare. The brand distinguishes itself through its commitment to clean, effective ingredients, aiming to support women throughout their entire cycle. With an emphasis on sustainability and sensitivity, Rael addresses the diverse needs of individuals, including those managing irregular cycles or conditions like PCOS. Founded by Yanghee Paik, Rael merges Korean beauty innovation with a holistic philosophy to personal care, positioning itself as a leader in the evolving wellness market.
How much funding has Rael raised?
Rael has raised a total of $52.9M across 3 funding rounds:
Series A
$17.5M
Debt
$350K
Series B
$35M
Series A (2018): $17.5M with participation from SoftBank Ventures Asia, Pritzker Group Venture Capital, and Mirae Asset Venture Investment
Debt (2020): $350K led by PPP
Series B (2022): $35M supported by Signite Partners, Aarden Partners, Colopl Next, and ST Capital
Key Investors in Rael
Signite Partners
Signite Partners is a venture capital firm under the Shinsegae Group, focusing on lifestyle innovation through technology in beauty, fashion, and retail. They aim to ignite a startup ecosystem that enhances everyday life and support entrepreneurs in these dynamic industries.
Colopl Next
Colopl Next is a venture capital firm that invests in a wide range of startups, particularly in BtoC entertainment sectors, and supports young entrepreneurs. They leverage the expertise of the COLOPL Group to enhance everyday life through innovative investments.
SoftBank Ventures Asia
SoftBank Ventures Asia is the early-stage venture capital arm of the SoftBank Group, specializing in ICT investments including AI, IoT, and smart robotics. They seek early to growth-stage startups with strong global business potential.
What's next for Rael?
The recent major strategic investment signals Rael's readiness for accelerated expansion and market penetration. With a foundation built on clean ingredients and a holistic approach to women's health, the company is well-positioned to capitalize on the growing demand for specialized wellness products. Future endeavors will likely focus on scaling operations, enhancing product development, and broadening its reach within the global market. The sustained backing from prominent investors suggests a strategic roadmap aimed at solidifying Rael's brand presence and further innovating within the competitive menstrual and cycle care sector.
See full Rael company page
